Certara, Inc. (CERT) Stock Analysis
A live, multi-source view of Certara, Inc. (CERT): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Certara, Inc.
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. It also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix cloud that offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes.
Sector: Healthcare · Industry: Health Information Services · United States · 1,515 employees · certara.com
Key statistics · as of 2026-09-05
As of 2026-09-05, Certara, Inc. (CERT) had a market capitalization of $1.21B (forward 20.3) and a beta of 1.41; the shares traded in a 52-week range of $4.45 – $13.88 (-24.0% over the year).
- Market cap
- $1.21B
- Enterprise value
- $1.33B
- Forward P/E
- 20.3
- Price / book
- 1.25
- EPS (trailing)
- $-0.14
- EPS (forward)
- $0.39
- Payout ratio
- 0.0%
- 52-week range
- $4.45 – $13.88
- 52-week change
- -24.0%
- Beta
- 1.41
- Average volume
- 3.9M
- Shares outstanding
- 152.5M
- Short % of float
- 25.91%
- Profit margin
- -16.2%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-08
In RapidTradeView’s 2026-09-08 scan of the US universe, Certara, Inc. (CERT) last closed at $7.94 (the last completed close before that scan).
Technicals at the scan: RSI 49 (neutral territory), price -3.1% versus its 20-day average, 20-day versus 50-day average spread +7.6%, MACD histogram -0.08.
Sentiment inputs: StockTwits 88% bullish; analyst consensus score 58/100.
Next scheduled company event: in 58 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
RapidTradeView has recorded no Congress or insider filing for CERT in the last 90 days. Coverage of House, Senate and SEC Form 4 filings began in July 2026, and insider sells are tracked for universe tickers only, so this is our record, not a guarantee that nothing was filed. Who is trading what
RapidTradeView pick record
CERT has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Certara, Inc. (CERT) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell CERT.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.